Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Organism that Causes Buruli Ulcer Isolated and Characterized

By Labmedica staff writers
Posted on 07 Apr 2008
Buruli ulcer is a neglected, devastating, necrotizing disease, and sometimes produces massive, disfiguring ulcers. More...
It has long been believed that it is caused by Mycobacterium ulcerans, an environmental pathogen transmitted to humans from aquatic niches, but until now, the organism has not been isolated in pure culture from environmental sources.

The disease occurs predominantly in impoverished, humid, tropical, rural areas of Africa, where the incidence has been increasing, surpassing tuberculosis, and leprosy (two other diseases caused by mycobacteria) in some regions. Besides being a disease of the poor, Buruli ulcer is a poverty-promoting chronic infectious disease.

An international team of 17 researchers from four countries isolated from the environment and fully characterized the organism that causes Buruli ulcer. The study, published March 26, 2008, in the open-access journal PLoS Neglected Tropical Diseases, lends support to the idea that the organism, M. ulcerans, is transmitted to humans from environmental aquatic niches, rather than from person to person.

Françoise Portaels, from the Institute of Tropical Medicine (Antwerp, Belgium), and colleagues in Ghana, Portugal, and the United States, described how they isolated and characterized a M. ulcerans strain from the environment. The strain has microbiological features typical of African strains of M. ulcerans and it was isolated from an aquatic insect (the Water Strider) from a Buruli ulcer-endemic area in Benin, West Africa.

"Our findings support the concept that Mycobacterium ulcerans is a pathogen of humans with an aquatic environmental niche,” said the authors "and will have positive consequences for the control of this neglected and socially important tropical disease.”

In a related commentary, Tim Stinear, from Monash University (Clayton, Australia), and Paul Johnson, from the Austin Hospital (Heidelberg, Australia), who were not involved in the study, say that the new study is "a major achievement and will serve as the definitive reference point for scientists' intent on revealing the ecology, environmental reservoir, and precise mode of transmission of Mycobacterium ulcerans.”


Related Links:
Institute of Tropical Medicine
Monash University
Austin Hospital

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.